chrisvoncsefalvay/vaers-outcomes huggingface dataset:
suspected vaccination failure; shingles; This case was reported by a consumer via interactive digital media and described the occurrence of suspected vaccination failure in a female patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine, the patient experienced vaccination failure (serious criteria GSK medically significant) and shingles. On an unknown date, the outcome of the vaccination failure and shingles were unknown.   It was unknown if the reporter considered the vaccination failure and shingles to be related to Shingles vaccine.  Additional details were provided as follows: The patient was reporter's sister. The age at vaccination was not reported. The patient was vaccinated and experienced shingles. This case was considered as suspected vaccination failure since the details regarding completion of primary vaccination schedule, time to onset and laboratory confirmation of shingles were not provided. This case has been linked with the case US2021AMR200633 reported by same reporter.; Sender's Comments:  US-GLAXOSMITHKLINE-US2021AMR200633:same repoter
This is a spontaneous report from a female pt who in April 1999, received her 1st dose of Lymerix, with no untoward effects. In May 1999, she received the 2nd dose and 1 day later, experienced severe joint aches, a respiratory infection, hacking cough and generalized fatigue and sleepiness. She remained in bed for 1 week. The pt was treated with an antibiotic and Lymerix was discontinued. The most recent information received on 7/9/1999, reports the symptoms resolved.
2wks p/receiving chicken pox vax pt became exhausted, h/a, swollen lymph glands, elevated lymphocyte count;no known cause;blood count was abn for 5months & is finally normalizing now MAR96
Light headed, chills & fever for approx 4-5 hours; body aches for 24 hours; took 1000mg of acetaminophen every 8 hours; completely fine & back to normal after 24 hours.
PATIENT GOT 2 VACCINES, A FEW MINULTES LATER , SHE WAS UNRESPONSIVE AND CNS SIDE EFFECTS
Tiredness and lack of energy persisted since 2nd vaccine. A month before, I had kidney stones which I had never had. It was very severe. Spent 3 weeks at home and had to have 2 different procedures. Had 3rd vaccine on 9/29/2021. Tiredness and lack of energy has worsed. Soreness in vaccinated arm continues to occur at random times. Nerve pain in left leg has begun, not sure if related or not.
About 10 min after the shot pt started vomiting and feeling nausea pt denied being dizzy just upset stomach but mentioned they also felt a little weak. Offered to call 911 but pt guardian refused. Stayed with pt until they got up and left to go to the bathroom upfront  they never returned to the pharmacy.
Formed pea size lump under the skin that lasted 2 months.  Reports fatigue since vaccination.
14FEB98 2 days p/vax arm swollen x3 shoulder to below elbow-red, hot, tender-very very edematous;afeb;sent to ER;
Site of injection very sore for 10 days. Aches and pains all over for the last 10 days...rib cage felt as if it was bursting...flu like symptoms all over.
Pt received Influenza vaccine IM on Tuesday September 22, 2009.  That evening pt had leg pain causing pt to limp and parents noticed swelling and redness.  The symptoms have persisted.  Pt was seen By Dr. in office on 9/25/09 and has large local swelling and erythema.  Dr feels it is from the vaccine pt received.
25OCT93 430PM tired, felt funny, sore arm & swollen from shoulder to elbow;  26OCT93 lt work a/noon-collapsed & slept rest of day-awoke w/fever @ 10PM 104 called MD 1030PM; took APAP & Advil; 27OCT93 joints hurt, h/a, arm swollen & painful;
1 hour after administration, she felt tingling and numbess up her left sife of neck to ear. Then she felt pressure/pain behind her left ear and left teeth and left side of tongue felt numb. She went to the ED and they said she was having an allergic reaction to the vaccine, however it wasn't severe.
Same as my previous dose on 09/10/21 but symptoms getting worse. Ringing in ears, vertigo, burning mouth, headache.
Severe chills for hours, high fever, head aches, fatigue, and hallucinations. Being disoriented.
This is a spontaneous report from a contactable consumer reported for herself. This 68-year-old female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; Lot Number EL9265), via an unspecified route of administration at single dose in the left arm on 31Jan2021 11:30 for covid-19 immunisation. Medical history included liver disorder, kidney disease, asthma, allergies to PCN, Sulpr, Iodine dye, pineapple, spinach. Concomitant medications were not reported. On 01Feb2021, the patient experienced achy, fever, chills and neck muscle sorenesswith. No treatment required. The outcome of the events was recovered on an unspecified date in Feb2021. The vaccine was administered at Health Clinc and  facility. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient had not been tested for COVID-19 since the vaccination. The patient had not been diagnosed with COVID-19 prior the vaccination.
Pt. reported nausea and throat swelling @ 1st vaccine.  Did not receive 2nd.
FLU LIKE SYMPTOMS, INCLUDING SHORTNESS OF BREATH, HEADACHES, NOT MOVING TO PASS TIME, CONFUSION.
Information regarding PREVNAR was received from a healthcare professional regarding a 9 month old male patient who experienced pneumococcal meningitis. The patient received the third dose on an unspecified date. The patient was taken to the walk in patient clinic and was lethargic in May 2010. The patient was admitted to the hospital with a diagnosis of pneumococcal meningitis. It is unknown if any treatment was given. Outcome was unknown. No additional information was available at the time of this report.
This case was reported by a consumer via call center representative and described the occurrence of injection site pain in a 75-year-old female patient who received SHINGRIX for prophylaxis. On 25th January 2019, the patient received the 1st dose of SHINGRIX. On 25th January 2019, less than a day after receiving SHINGRIX, the patient experienced injection site pain, headache, fatigue, shivering, sweating, fever, gastrointestinal disorder and pain in arm. On 26th January 2019, the outcome of the injection site pain, headache, fatigue, shivering, sweating, fever and gastrointestinal disorder were recovered/resolved. On an unknown date, the outcome of the pain in arm was recovered/resolved.  It was unknown if the reporter considered the injection site pain, headache, fatigue, shivering, sweating, fever, gastrointestinal disorder and pain in arm to be related to SHINGRIX. Additional details were provided as follows: In the evening, the patient experienced pain at injection site, headache, fatigue, shivering, sweating, fever, GI problems which went away the next day. The patient stated that she had pain on the arm that did not get vaccine. The patient confirmed that she would not get more than one vaccine. The reporter did not consent to follow-up. This case has been linked with case US2019028262 (patient's husband), reported by same reporter.
Had a seizure this morning, took her to the ER. Mother wants to know if the flu shot had anything to do with it. Had flu shot yesterday. 1-15-13 P.C - see above. Approx 20 hours after being given to flu shot developed LOC. Had been fine, but right before having LOC she complained of pain in the arm where the flu shot was given (no localized rxn noted). She fell to the ground and had LOC x 2 min. During this time she was staring and had some "rocking" movements. When she regained consciousness, she seemed normal. Ambulance squad came -> VS (no fever) and BS were normal. Seen in ER. EKG WNL. Pt scheduled for an EEG next wk. No treatment was given. Imp - LOC -> ? seizure vs vagal rxn. Rec - observation; get EEG. Would consider avoiding flu shot in the future. VAERS form submitted.
INCREASED BLOOD PRESSURE; This spontaneous report received from a patient concerned a 73 year old female. The patient's height, and weight were not reported. The patient's concurrent conditions included lupus, and rheumatoid arthritis. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unk) dose was not reported, administered on 23-MAR-2021 for prophylactic vaccination. Batch number was not reported and has been requested. No concomitant medications were reported. On an unspecified date, the subject experienced increased blood pressure. Laboratory data (dates unspecified) included: Blood pressure (NR: not provided) 190 unspecified. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient had not recovered from increased blood pressure. This report was non-serious.
12 days after the injection woke up with rash around the injection site. It covers most of my upper arm and itches.
Severe swelling of lymph node in left arm pit and minor swelling in other lymph nodes; Severe fatigue; This is a spontaneous report from a contactable consumer (patient). A 41-year-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection; Batch/Lot number: EW0176, Expiration date was not reported), via an unspecified route of administration (administered on the left arm) on 15May2021 17:30 (at the age of 41-years-old) as 2nd dose, single dose for COVID-19 immunisation. The patient's medical history was not reported. The patient has no other medications received within 2 weeks of vaccination. Prior to vaccination, the patient has not been diagnosed with COVID-19.  The patient didn't receive any other vaccines within 4 weeks prior to COVID vaccine. The patient was previously vaccinated with the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection; Batch/Lot number: EW0170, Expiration date was not reported), via an unspecified route of administration (administered on the right arm) on 24Apr2021 17:15 (at the age of 41-years-old) for COVID-19 immunisation. The patient experienced severe fatigue on 16May2021 07:00 and severe swelling of lymph node in left arm pit and minor swelling in other lymph nodes on 17May2021 07:00. The events were assessed as non-serious. No treatment was received for the events. Since the vaccination the patient has not been tested for COVID-19. The outcome of the events was recovering.
Pt got shot on 9/24/13 and on or around 12/7/13 came back to store where shot was administered and stated to RPH on duty that administering RPH gave flu shot too high on arm, causing discomfort and MD visits since then.
This medically confirmed report (initial receipt 07-Nov-2013) concerns a 60-year-old male patient. On an unspecified date, the patient received an unspecified influenza virus vaccine (manufacturer and batch number not provided). On an unspecified date, the patient developed myelitis. Outcome was not reported.
almost dies becomes paralyzed for over one year; seizures; has to live with Transverse myelitis for the rest of their life; has to relearn to walk again; This case was reported by a consumer via  interactive digital media and described the occurrence of paralysis in a male patient who received Men B NVS (Meningococcal B vaccine) for prophylaxis.   On an unknown date, the patient received Meningococcal B vaccine. On an unknown date, unknown after receiving Meningococcal B vaccine, the patient experienced paralysis (serious criteria GSK medically significant and life threatening), seizure (serious criteria GSK medically significant), myelitis transverse (serious criteria GSK medically significant) and unable to walk. On an unknown date, the outcome of the paralysis and unable to walk were unknown and the outcome of the seizure and myelitis transverse were not recovered/not resolved.   The reporter considered the paralysis, seizure, myelitis transverse and unable to walk to be related to Meningococcal B vaccine.  Additional details were provided as follows: The reporter was patient's wife. The age at vaccination was not reported. The reporter said it was hard to forget that the patient was perfectly healthy before the vaccine got the said life saving vaccine and almost died and became paralyzed for over one year and had to relearn to walk again. The patient had seizures and had to live with transverse myelitis for the rest of their life.  Also the patient would not be allowed anymore vaccines because they could kill him and patient's kids can't have them either because of the patient's reaction.  The reporter commented one size does not fit all and guess you may have forgotten that.
4 DAYS AFTER RECIEVING ANTHRAX VACCINE MEMBER HAD A RING OF RAISED BUMPS AROUND INJECTION SITE THAT ITCHED. MEMBER STATES THAT BUMPS SUBSIDED AFTER APROXIMATELY 5 DAYS. NO REDNESS, A SMALL AMOUNT OF SWELLING. BENADRYL WAS TAKEN AND HELPED THE SYMPTOMS.
Injection site reaction: warmth, redness, swelling. Stated that he did apply ice to the are one time. No other symptoms. Still has symptoms.
Hives on face, trunk and extremities within 6 hours of vaccines; No signs anaphylaxis
Diarrhea; Fever; Swollen lymph nodes; Chills; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of DIARRHOEA (Diarrhea), PYREXIA (Fever), LYMPHADENOPATHY (Swollen lymph nodes) and CHILLS (Chills) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced DIARRHOEA (Diarrhea), PYREXIA (Fever), LYMPHADENOPATHY (Swollen lymph nodes) and CHILLS (Chills). At the time of the report, DIARRHOEA (Diarrhea), PYREXIA (Fever), LYMPHADENOPATHY (Swollen lymph nodes) and CHILLS (Chills) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No relevant concomitant medications were reported. No treatment information was provided.
Sweatiness and shortness of breath immediately after vaccination, stood up to go get snack & walked a short distance before getting blurred vision/ringing in ears and then fainted
Had a pain in my arm; Flu like symptoms; Chills; Body aches; Runny nose; This is a spontaneous report from a contactable consumer reported for herself. A female patient of an unspecified age received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on 24Jan2021 at SINGLE DOSE for covid-19 immunisation. The patient medical history was not reported. The patient's concomitant medications were not reported. The caller stated "I had the first dose of the vaccine yesterday on 24Jan2021 around 10:00 and I am having more side effects and want to know how long it is going to last. I was fine and had a pain in my arm. Not until maybe midnight, I started feeling more flu like symptoms and took Tylenol and helped, I woke up this morning on 25Jan2021, with chills, body aches, runny nose, and not wanting to do anything. I came to work and pushed myself. Feeling like this, I know it's not covid but what do you suggest." Outcome of the events was unknown. Information on the lot/batch number has been requested.
Pt given MMR & flu shot on same day. Had "flu-like" symptoms and upper respiratory symptoms for 36 hours (onset 24 hrs post vaccination).
No adverse event; Monovalent doses administered after the BUD to patients; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Monovalent doses administered after the BUD to patients) and NO ADVERSE EVENT (No adverse event) in a 43-year-old male patient who received mRNA-1273 (Spikevax) (batch no. 059H21A) for COVID-19 prophylaxis.     No Medical History information was reported.    On 04-Feb-2022, the patient received dose of mRNA-1273 (Spikevax) (Intramuscular) 1 dosage form. On 04-Feb-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Monovalent doses administered after the BUD to patients). On an unknown date, the patient experienced NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Monovalent doses administered after the BUD to patients) and NO ADVERSE EVENT (No adverse event) outcome was unknown.        For mRNA-1273 (Spikevax) (Intramuscular), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for EXPIRED PRODUCT ADMINISTERED (Monovalent doses administered after the BUD to patients).   It was unknown if the patient received any other vaccines in the 4 weeks prior to COVID-19 vaccine. No concomitant drug was reported. Reportedly, the patient was eligible for COVID-19 vaccine. No treatment drug was reported.
Red area on Rt upper arm 6 1/2 in x 4 1/2 Swollen from 3 in Below shoulder joint to 2 in above elbow Rt arm.
Patient had COVID SHOT # 1 on 1/29/2021 and COVID SHOT # 2 on 2/19/2021. She began to have abdominal pain and bloating. She had her gallbladder evaluated and had a cholecystectomy 5/2021. She continued to have abdominal pain and went to the ER in June 2021 and diagnosed with colitis. She persisted in having abdominal pain and diarrhea. She had a colonsocopy performed in June and later had Colon cancer diagnosed. She had a right Hemicolectomy. No family history of Colon cancer in her family.
No adverse event; Administered Moderna Covid-19 Bivalent doses to treat long-haul COVID symptoms; 42 Patients received bivalent booster with 38 having improvement of symptoms; This spontaneous case was reported by a physician and describes the occurrence of OFF LABEL USE (Administered Moderna Covid-19 Bivalent doses to treat long-haul COVID symptoms), THERAPEUTIC RESPONSE UNEXPECTED (42 Patients received bivalent booster with 38 having improvement of symptoms) and NO ADVERSE EVENT (No adverse event) in a patient of an unknown age and gender who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) for Post-acute COVID-19 syndrome.     No Medical History information was reported.    In 2023, the patient received dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) 1 dosage form. In 2023, the patient experienced OFF LABEL USE (Administered Moderna Covid-19 Bivalent doses to treat long-haul COVID symptoms) and THERAPEUTIC RESPONSE UNEXPECTED (42 Patients received bivalent booster with 38 having improvement of symptoms). On an unknown date, the patient experienced NO ADVERSE EVENT (No adverse event). At the time of the report, OFF LABEL USE (Administered Moderna Covid-19 Bivalent doses to treat long-haul COVID symptoms), THERAPEUTIC RESPONSE UNEXPECTED (42 Patients received bivalent booster with 38 having improvement of symptoms) and NO ADVERSE EVENT (No adverse event) outcome was unknown.        For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessments were provided for OFF LABEL USE (Administered Moderna Covid-19 Bivalent doses to treat long-haul COVID symptoms) and THERAPEUTIC RESPONSE UNEXPECTED (42 Patients received bivalent booster with 38 having improvement of symptoms).    No concomitant medication was provided by reporter.  No treatment medication was provided by reporter.  Reporter stated she has been administering the 65 plus bivalent dose to her patients who have symptoms of long-haul COVID and has seen 88-90% success rate in resolving the symptoms of long-haul COVID.  It was reported that, vaccine was given to patients for long COVID between Mar-2023 and 01-Aug-2023. 42 Patients received bivalent booster with 38 having improvement of symptoms and 50s or more. Patient was treated skin lesions, scary brain, body aches. No adverse reactions occurred.  This case contains information about patient 9 out of 42 patients.   This case was linked to US-MODERNATX, INC.-MOD-2023-735199 (E2B Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2023-735199:Master case
Myalgia Narrative:  dose 2 day 2- Body aches, chills  Other Relevant History:
Headaches, neck spasm with blurred vision at times started 3 days after administration of Moderna COVID-19 Vaccine EUA.
Swelling, redness around injection site; tenderness with pressure; swelling bigger than golfball injection site LDUA; SQ location of varicella vaccine Lot # 0551Z Exp date 4/8/12 manf. - MSD.
The patient expressed feeling light-headed and dizzy.  His vitals were 130/68, 97% RA, and 85 HR.  The patient was given OJ and a banana, denies n/v/d, and was not diaphoretic.  His brother was in the room and stated, "he does this ALL the time."  The patient was still dizzy so 911 was called.  Staff stayed with the patient until EMS arrived (patient remained conscious and stable).  EMS preformed BGM 146, attached heart monitor, communicated with patient, and walked patient to the rig for transport to escalated care.
Patient began to show muscle weakness in late afternoon on 1/31/21. On 2/1/21 she was unable to walk, not even one step. She had difficulty swallowing, was unable to feed herself, and was extremely lethargic. She was unable to remain awake all day and had to be shaken unusually hard to wake up. She appeared confused/ disoriented upon waking. She did not have a fever or report of any pain. Her BP, pulse, and O2 were all normal.  She did present with any indications of a stroke. Slight improvement began late afternoon on 2/2/21. On 2/3/21 all of these conditions had disappeared and she was back to her normal self and activities.